Subscribe To Our Free Newsletter |
Focused on volume growth as main driver of business: Bharath Uppiliappan, Dr Lal PathLabs
So we will continue to build the bundle test portfolio, not only in Swasthfit, but also in super specialty segments. For example, how do we kind of give a seamless journey on cancer care or autoimmunity or reproductive diagnostics? So bundle test is an across the portfolio, across the spectrum kind of focus for us, not just restricted to a few tests and so on. So yes, on the whole bundle test portfolio contribution will move up in the years to come as well.